Dosing guidelines suggest starting at a dose of 1.5 milligrams and gradually increasing to the maintenance dose (the dose found to be most effective in clinical trials) of 25 mg, depending on how the person responds and how strong side effects are
Other mechanisms presumably involve active tubular secretion via renal transporters (Organic Anion Transporter-3 (OAT3) or P-glycoprotein (P-gp))
Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue
This dual role suggests that p53 may act as a promising therapeutic target in OA therapy, achieving the synergistic effect of eliminating lesioned cells while protecting normal tissues by precisely regulating the balance between apoptosis and ferroptosis in different cell populations
Analysts at JP Morgan recently doubled their predictions for the incretin class to $71 billion within the next 10 years
In April 2023, KFF fielded a survey to a nationally representative sample of 1,479 adults in the United States from the SSRS Opinion Panel to obtain population estimates of GLP-1 agonist knowledge, attitudes, and use (Montero et al., 2024)
